Herbal Dispatch Inc. posted a 74% increase in gross profit for Q2 2026, reaching $0.75 million, fueled by strong growth in its medical cannabis and international export businesses. Medical sales more than doubled to $0.9 million, largely due to expansion in the veteran medical channel, while export sales rose 45% year-over-year. The company improved its gross margin to 28.8% by shifting focus to higher-margin medical and export channels, despite a slight revenue decline from reduced recreational sales. Herbal Dispatch expects to achieve consistent positive adjusted EBITDA and operating cash flow starting Q3 2026 as it continues to grow these segments.
XPeng Inc. delivered 39,107 vehicles in August 2026, marking a 4% increase from the previous year. The company launched pre-sales of its new XPeng G9L model in China and made progress in its Robotaxi business by obtaining a permit for remote testing ...
The burn rate of Shiba Inu (SHIB) tokens has surged by 1,020%, with 20.82 million SHIB tokens recently moved to dead wallets. This significant increase in token burning reduces the circulating supply, potentially increasing scarcity and value for hol...
Broadcom is rated as a 'Hold' because its current market price aligns with valuation models ranging from $346.03 to $382.37. The recent stock underperformance is linked to VMware security issues and risks to the software segment's high operating marg...
Blue Owl Capital Corporation (OBDC) shares are trading at a 21% discount to their net asset value (NAV), presenting an attractive investment opportunity with an 11% dividend yield. The company's adjusted net investment income of $0.34 per share comfo...
On August 31, 2026, MEXC launched a crypto payment card offering up to 10% USDT cashback and up to 7% annual yield on USDT balances. However, under EU regulation MiCAR Article 50, licensed providers cannot pay interest on regulated stablecoins, which...
